U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C9H12ClN5O
Molecular Weight 241.677
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MOXONIDINE

SMILES

COC1=C(NC2=NCCN2)C(Cl)=NC(C)=N1

InChI

InChIKey=WPNJAUFVNXKLIM-UHFFFAOYSA-N
InChI=1S/C9H12ClN5O/c1-5-13-7(10)6(8(14-5)16-2)15-9-11-3-4-12-9/h3-4H2,1-2H3,(H2,11,12,15)

HIDE SMILES / InChI
Molecular Formula C9H12ClN5O
Molecular Weight 241.677
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:46:52 UTC 2023
Edited
by admin
on Fri Dec 15 15:46:52 UTC 2023
Record UNII
CC6X0L40GW
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MOXONIDINE
EP   INN   MART.   MI   USAN   WHO-DD  
INN   USAN  
Official Name English
MOXONIDINE [MART.]
Common Name English
BE5895
Code English
BE-5895
Code English
LY326869
Code English
5-PYRIMIDINAMINE, 4-CHLORO-N-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)-6-METHOXY-2-METHYL-
Systematic Name English
LY-326869
Code English
Moxonidine [WHO-DD]
Common Name English
CYNT
Brand Name English
BDF-5896
Code English
4-Chloro-5-(2-imidazolidinyldeneamino)-6-methoxy-2-methylpyrimidine
Common Name English
moxonidine [INN]
Common Name English
MOXONIDINE [USAN]
Common Name English
MOXONIDINE [MI]
Common Name English
MOXONIDINE [EP MONOGRAPH]
Common Name English
BDF5896
Code English
Classification Tree Code System Code
WHO-ATC C02LC05
Created by admin on Fri Dec 15 15:46:52 UTC 2023 , Edited by admin on Fri Dec 15 15:46:52 UTC 2023
WHO-VATC QC02LC05
Created by admin on Fri Dec 15 15:46:52 UTC 2023 , Edited by admin on Fri Dec 15 15:46:52 UTC 2023
WHO-ATC C02AC05
Created by admin on Fri Dec 15 15:46:52 UTC 2023 , Edited by admin on Fri Dec 15 15:46:52 UTC 2023
NCI_THESAURUS C270
Created by admin on Fri Dec 15 15:46:52 UTC 2023 , Edited by admin on Fri Dec 15 15:46:52 UTC 2023
WHO-VATC QC02AC05
Created by admin on Fri Dec 15 15:46:52 UTC 2023 , Edited by admin on Fri Dec 15 15:46:52 UTC 2023
Code System Code Type Description
INN
5207
Created by admin on Fri Dec 15 15:46:52 UTC 2023 , Edited by admin on Fri Dec 15 15:46:52 UTC 2023
PRIMARY
FDA UNII
CC6X0L40GW
Created by admin on Fri Dec 15 15:46:52 UTC 2023 , Edited by admin on Fri Dec 15 15:46:52 UTC 2023
PRIMARY
NCI_THESAURUS
C87629
Created by admin on Fri Dec 15 15:46:52 UTC 2023 , Edited by admin on Fri Dec 15 15:46:52 UTC 2023
PRIMARY
SMS_ID
100000088399
Created by admin on Fri Dec 15 15:46:52 UTC 2023 , Edited by admin on Fri Dec 15 15:46:52 UTC 2023
PRIMARY
MESH
C043482
Created by admin on Fri Dec 15 15:46:52 UTC 2023 , Edited by admin on Fri Dec 15 15:46:52 UTC 2023
PRIMARY
CAS
75438-57-2
Created by admin on Fri Dec 15 15:46:52 UTC 2023 , Edited by admin on Fri Dec 15 15:46:52 UTC 2023
PRIMARY
USAN
KK-103
Created by admin on Fri Dec 15 15:46:52 UTC 2023 , Edited by admin on Fri Dec 15 15:46:52 UTC 2023
PRIMARY
PUBCHEM
4810
Created by admin on Fri Dec 15 15:46:52 UTC 2023 , Edited by admin on Fri Dec 15 15:46:52 UTC 2023
PRIMARY
ChEMBL
CHEMBL19236
Created by admin on Fri Dec 15 15:46:52 UTC 2023 , Edited by admin on Fri Dec 15 15:46:52 UTC 2023
PRIMARY
MERCK INDEX
m7649
Created by admin on Fri Dec 15 15:46:52 UTC 2023 , Edited by admin on Fri Dec 15 15:46:52 UTC 2023
PRIMARY Merck Index
RXCUI
30257
Created by admin on Fri Dec 15 15:46:52 UTC 2023 , Edited by admin on Fri Dec 15 15:46:52 UTC 2023
PRIMARY RxNorm
EVMPD
SUB09092MIG
Created by admin on Fri Dec 15 15:46:52 UTC 2023 , Edited by admin on Fri Dec 15 15:46:52 UTC 2023
PRIMARY
DRUG BANK
DB09242
Created by admin on Fri Dec 15 15:46:52 UTC 2023 , Edited by admin on Fri Dec 15 15:46:52 UTC 2023
PRIMARY
EPA CompTox
DTXSID5045170
Created by admin on Fri Dec 15 15:46:52 UTC 2023 , Edited by admin on Fri Dec 15 15:46:52 UTC 2023
PRIMARY
WIKIPEDIA
MOXONIDINE
Created by admin on Fri Dec 15 15:46:52 UTC 2023 , Edited by admin on Fri Dec 15 15:46:52 UTC 2023
PRIMARY
DRUG CENTRAL
1856
Created by admin on Fri Dec 15 15:46:52 UTC 2023 , Edited by admin on Fri Dec 15 15:46:52 UTC 2023
PRIMARY
Related Record Type Details
ALPHA-2A ADRENERGIC RECEPTOR
TARGET -> AGONIST
Ki
Nischarin
TARGET -> AGONIST
Ki
Structure of MOXONIDINE
EXCRETED UNCHANGED
URINE
Related Record Type Details
Structure of 4-CHLORO-N-1H-IMIDAZOL-2-YL-6-METHOXY-2-METHYL-5-PYRIMIDINAMINE
METABOLITE -> PARENT
PLASMA
Structure of 1H-IMIDAZOLE-4,5-DIOL, 2-((4-CHLORO-6-METHOXY-2-METHYL-5-PYRIMIDINYL)AMINO)-4,5-DIHYDRO-
METABOLITE -> PARENT
URINE
Structure of 4-CHLORO-N-1H-IMIDAZOL-2-YL-6-METHOXY-2-METHYL-5-PYRIMIDINAMINE
METABOLITE -> PARENT
URINE
Structure of 1H-IMIDAZOL-5-OL, 2-((4-CHLORO-6-METHOXY-2-METHYL-5-PYRIMIDINYL)AMINO)-4,5-DIHYDRO-
METABOLITE -> PARENT
URINE
Structure of 2-HYDROXYMETHYL-4-CHLORO-5-(IMIDAZOLIDIN-2-YLIDENIMINO)-6-METHOXYPYRIMIDINE
METABOLITE -> PARENT
URINE
Related Record Type Details
Structure of MOXONIDINE
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Tmax PHARMACOKINETIC ORAL ADMINISTRATION

NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966